VERU INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
VERU INC. (VERU) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 334.21 thousand shares for the 12-month period ending 2021-09-30, per its 10-K filed 2022-12-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2022-12-05
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2020-12-31 was 1.03M shares.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-06-30 was 62.17K shares, a 5.54% increase year-over-year.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-03-31 was 59.88K shares.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2011-12-31 was 56.99K shares.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2021 was 334.21K shares.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 39.82K shares, a 32.73% decline from fiscal 2011.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 59.20K shares, a 2.87% decline from fiscal 2010.
- VERU INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2010 was 60.95K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2021-09-30 | 334.21K shares 10-K · filed 2022-12-05 | |||
| 2021-06-30 | 499.78K shares 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 744.82K shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 1.03M shares 10-Q · filed 2022-02-09 | |||
| 2012-09-30 | 39.82K shares 10-K · filed 2012-12-04 | |||
| 2012-06-30 | 62.17K shares 10-Q · filed 2012-07-31 | 59.90K shares 10-Q · filed 2012-07-31 | ||
| 2012-03-31 | 59.88K shares 10-Q · filed 2013-05-02 | 58.53K shares 10-Q · filed 2013-05-02 | ||
| 2011-12-31 | 56.99K shares 10-Q · filed 2013-01-30 | |||
| 2011-09-30 | 59.20K shares 10-K · filed 2012-12-04 | |||
| 2011-06-30 | 58.91K shares 10-Q · filed 2012-07-31 | 60.08K shares 10-Q · filed 2012-07-31 | ||
| 2010-09-30 | 60.95K shares 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |